Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis.

This paper reviews the progress which has been achieved with combination chemotherapy of experimental murine central nervous system trypanosomiasis. Successful treatments have been achieved with suramin followed by 5-nitroimidazoles; difluoromethylornithine in combination with bleomycin, 9-deazainosine, suramin, arsenicals, antimonials and diamidines; and also the arsenicals in combination with the 5-nitroimidazoles or nifurtimox. Pretreatment with prednisolone and azathioprine, to minimize reactive encephalopathies, and supportive treatment with oxygen are both indicated.
AuthorsF W Jennings
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1990 Sep-Oct Vol. 84 Issue 5 Pg. 618-21 ISSN: 0035-9203 [Print] ENGLAND
PMID2278054 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Nitroimidazoles
  • 4-nitroimidazole
  • Animals
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Forecasting
  • Humans
  • Meningoencephalitis (drug therapy)
  • Mice
  • Nitroimidazoles (therapeutic use)
  • Trypanosoma brucei brucei (drug effects)
  • Trypanosomiasis, African (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: